Cat. No.: DAA-001154
Product Information | |
---|---|
Product Name | Human IL-1β ELISA Kit |
Species | Human |
Description | Human IL-1β ELISA (Enzyme-Linked Immunosorbent Assay) kit is an in vitro enzyme-linked immunosorbent assay for the quantitative measurement of human IL-1β in plasma and cell culture supernatants. (Human IL-1β concentration is quite low in normal plasma, it may not be detected in this assay). This assay employs an antibody specific for human IL-1β coated on a 96-well plate. Standards and samples are pipetted into the wells and IL-1β present in a sample is bound to the wells by the immobilized antibody. The wells are washed and biotinylated anti-Human IL-1β antibody is added. After washing away unbound biotinylated antibody, HRP-conjugated streptavidin is pipetted to the wells. The wells are again washed, a TMB substrate solution is added to the wells and color develops in proportion to the amount of IL-1β bound. |
Sample Types | Cell Culture Supernatant, Plasma |
Detection Range | 0.48 pg/mL - 100 pg/mL |
Sensitivity | < 0.3 pg/mL |
Target Information | |
---|---|
Target Name | IL1B |
UniProt No. | P01584 |
Gene ID | 3553 |
Target Description | Potent proinflammatory cytokine. Initially discovered as the major endogenous pyrogen, induces prostaglandin synthesis, neutrophil influx and activation, T-cell activation and cytokine production, B-cell activation and antibody production, and fibroblast proliferation and collagen production. Promotes Th17 differentiation of T-cells. |
Alternative Names | Catabolin; H1; IFNβ inducing factor; IL 1; IL 1β; IL-1β; IL1; IL1β; IL1B; IL1B_HUMAN; IL1F2; Interleukin 1β; Interleukin 1β precursor; interleukin 1, β; Interleukin-1β; OAF; Osteoclast activating factor; OTTHUMP00000162031; Preinterleukin 1β; Preinterleukinβ; Pro interleukin 1β |
Shipping & Storage | |
---|---|
Sipping | Shipping on dry ice. |
Storage | Store at -20°C. Please refer to protocols. |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.